Aurion Biotech, Inc. ("Aurion Biotech"), a commercial-stage regenerative cell therapy company dedicated to restoring vision and working toward a future where blindness is eliminated, today announced ...

The FDA granted regenerative medicine advanced therapy designation to RTx-015 for the treatment of retinitis pigmentosa.

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery ...

A new study reveals an unexpected mechanism behind how humans develop sharp, color-rich vision before birth, pointing to a coordinated role between key biochemical signals in the retina.

RMAT designation enables intensified FDA engagement and potential accelerated pathways, implying preliminary clinical evidence for RTx-015 despite absent peer-reviewed efficacy details, endpoints, and ...

The FDA’s decision to extend the labeled duration of faricimab use in RVO beyond 6 months primarily reflects accumulated evidence supporting its continued efficacy and safety over longer treatment ...

The $96.8 million facility will include UNCP’s new College of Optometric Medicine and its Occupational Therapy program, as well as additional clinical sciences programs. The 74,000-square-foot ...

A nationwide program that connects families with veterinary specialists at no cost offers a free health screening for your ...

Harper Murray hadn't told her parents just how bad her double vision had got before she went to the opticians ...

Valitor, a biotechnology company engineering a new generation of ophthalmic medicines, today announced the company will present new preclinical data highlighting the potential of VLTR-559, a ...

These warning signs are subtle, but they're red flags you need medical attention.

UC Santa Barbara Professor will discuss her work, including “Meta/Physical Therapy,” her 2024 The Museum of Modern Art (MoMA) ...